Managing venous thrombosis in a pediatric patient with short bowel and congenital nephrotic syndromes: a case report emphasizing rivaroxaban level monitoring

• Egile Nagusiak: Marc Bosch-Schips (Egilea), Gonzalo Artaza (Egilea), Carlos Hernández-Mata (Egilea), Víctor Pérez Beltrán (Egilea), Vanessa Cabello Ruiz (Egilea), Pável Olivera Sumire (Egilea)
• Formatua: Liburua
• Argitaratua: Frontiers Media S.A., 2024-04-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Direct Oral Anticoagulants (DOACs) typically exhibit a predictable pharmacokinetic and pharmacodynamic response at a fixed dose, not necessitating monitoring under standard conditions. Yet, in specific clinical scenarios that can impair it, like Congenital Nephrotic Syndrome (CNS) or Short Bowel Syn...